KONICA MINOLTA 3rdQuarter/FY2017 ending in March 2018 Consolidated Financial Results  


Healthcare Business

Prev. Page Next Page Download the PDF
In the Healthcare Business, the growth in sales of digital products increased both revenue and profit over the nine-month period, even when the first-half profit from liquidation of assets is excluded.
As a 3Q summary for the healthcare (modality) business unit, strengthened cooperation on digital radiography (DR) with major X-ray system manufacturers in the US is yielding results from the strategy of selling their systems in combination with Konica Minolta DR. This, together with other factors, is expanding unit sales. Another factor in this favorable performance is the progressive shift from computed radiography (CR) to DR in North America. Ultrasound products also continue to yield solid sales in Japan, and sales volume is expanding year on year in the US and in China, as well. Service contracts also continue to grow, contributing to heightened profitability.
Increasing sales by the medical IT business unit in the US are contributing to revenue, with service contracts also expanding steadily.